KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹307 Cr | ₹251 Cr | ₹456 Cr | ₹262 Cr | ₹139 Cr |
What is the latest Revenue of KWALITY PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹307 Cr |
Mar2023 | ₹251 Cr |
Mar2022 | ₹456 Cr |
Mar2021 | ₹262 Cr |
Mar2020 | ₹139 Cr |
How is Revenue of KWALITY PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹307 Cr | 22.36 | |
Mar2023 | ₹251 Cr | -44.97 | |
Mar2022 | ₹456 Cr | 74.11 | |
Mar2021 | ₹262 Cr | 88.10 | |
Mar2020 | ₹139 Cr | - |
Compare Revenue of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹870.0 Cr | 5.7% | -9.4% | 98.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | 5.7% |
-9.4% |
98.3% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses